On Monday, HCW Biologics Inc (NASDAQ: HCWB) opened lower -13.14% from the last session, before settling in for the closing price of $0.49. Price fluctuations for HCWB have ranged from $0.21 to $2.52 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -39.43% over the past five years. Company’s average yearly earnings per share was noted 18.57% at the time writing. With a float of $19.75 million, this company’s outstanding shares have now reached $37.82 million.
Let’s look at the performance matrix of the company that is accounted for 45 employees. In terms of profitability, gross margin is 17.59%, operating margin of -1060.88%, and the pretax margin is -1067.83%.
HCW Biologics Inc (HCWB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of HCW Biologics Inc is 47.77%, while institutional ownership is 8.10%.
HCW Biologics Inc (HCWB) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 18.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.29% during the next five years compared to -34.57% drop over the previous five years of trading.
HCW Biologics Inc (NASDAQ: HCWB) Trading Performance Indicators
Check out the current performance indicators for HCW Biologics Inc (HCWB). In the past quarter, the stock posted a quick ratio of 0.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.00, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of HCW Biologics Inc (HCWB)
HCW Biologics Inc (NASDAQ: HCWB) saw its 5-day average volume 3.35 million, a negative change from its year-to-date volume of 14.09 million. As of the previous 9 days, the stock’s Stochastic %D was 28.90%. Additionally, its Average True Range was 0.11.
During the past 100 days, HCW Biologics Inc’s (HCWB) raw stochastic average was set at 9.25%, which indicates a significant decrease from 26.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 392.17% in the past 14 days, which was higher than the 297.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4045, while its 200-day Moving Average is $0.6421. Nevertheless, the first resistance level for the watch stands at $0.4688 in the near term. At $0.5138, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5475. If the price goes on to break the first support level at $0.3901, it is likely to go to the next support level at $0.3564. The third support level lies at $0.3114 if the price breaches the second support level.
HCW Biologics Inc (NASDAQ: HCWB) Key Stats
There are currently 37,823K shares outstanding in the company with a market cap of 16.04 million. Presently, the company’s annual sales total 2,840 K according to its annual income of -24,990 K. Last quarter, the company’s sales amounted to 430 K and its income totaled -3,900 K.
